Diploma

The origins of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) are rooted in the Indian Cancer Research Centre (ICRC), which was established in 1952 in Parel, Mumbai, under the purview of the Ministry of Health, Government of India.

The Dishman Group of Companies was founded in 1983 by Janmejay R. Vyas, Chairman of the Dishman Group. Since that time, the Dishman Group's focus has been on the research and development of various in-house technologies to manufacture quaternary ammonium compounds (quats) and active pharmaceutical ingredients.

Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally. With a presence in over 70 countries, Emcure's goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for a walk in interview for Formulations Manufacturing plant (SEZ- I, Matoda) Ahmedabad

Sun Pharma is the fourth largest generic pharmaceutical company in the world It is also India's largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high quality medicines trusted by customers and patients in over ISO countries and has multiple manufacturing facilities and R&D centers. Our leadership is approachable, recognizes people's passions for growth, gives them a voice and empowers them to make a positive change.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today. Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Otsuka Pharmaceutical India Private Limited is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a leader in intravenous nutrition products, we are committed to being the best partner of patients and healthcare professionals in the field of clinical nutrition.

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy. TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.

In pharmaceutical vertical, the family has two companies – Windlas Biotech Limited (WBL) and Windlas Healthcare Private Limited (WHC). WBL was founded in year 2000 with and provides contract manufacturing services for the Indian pharma market, employing over 400 staff and workers, and has a revenue of about Rs. 80 crores in the last fiscal (FY ‘08-’09). WBL also promotes its own branded generic products in India with a small sales team of 180 people.